Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2349-67-9

Post Buying Request

2349-67-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2349-67-9 Usage

Chemical Properties

White or pale yellow to cream powder

Uses

Different sources of media describe the Uses of 2349-67-9 differently. You can refer to the following data:
1. 5-Amino-1,3,4-thiadiazole-2-thiol is a thiadiazole derivative with antibacterial acitivity used in the preparation of herbicides as well as carbonic anhydrase inhibitors.
2. 5-amino-1,3,4-thiadiazole-2-thiol was used to prepare new amines exhibiting anti-convulsant activity.

Check Digit Verification of cas no

The CAS Registry Mumber 2349-67-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,4 and 9 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2349-67:
(6*2)+(5*3)+(4*4)+(3*9)+(2*6)+(1*7)=89
89 % 10 = 9
So 2349-67-9 is a valid CAS Registry Number.
InChI:InChI=1/C2H3N3S2/c3-1-4-5-2(6)7-1/h(H2,3,4)(H,5,6)

2349-67-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A11451)  2-Amino-5-mercapto-1,3,4-thiadiazole, 98%   

  • 2349-67-9

  • 25g

  • 358.0CNY

  • Detail
  • Alfa Aesar

  • (A11451)  2-Amino-5-mercapto-1,3,4-thiadiazole, 98%   

  • 2349-67-9

  • 100g

  • 709.0CNY

  • Detail
  • Aldrich

  • (127906)  5-Amino-1,3,4-thiadiazole-2-thiol  98%

  • 2349-67-9

  • 127906-50G

  • 519.48CNY

  • Detail

2349-67-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Amino-1,3,4-thiadiazole-2-thiol

1.2 Other means of identification

Product number -
Other names 5-Amino-1,3,4-thiadi

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2349-67-9 SDS

2349-67-9Synthetic route

carbon disulfide
75-15-0

carbon disulfide

thiosemicarbazide
79-19-6

thiosemicarbazide

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

Conditions
ConditionsYield
With choline chloride; urea at 80℃; for 2h;96.9%
In N,N-dimethyl-formamide for 6h; Reflux;89%
With sodium carbonate In ethanol for 5h; Reflux;89%
2-mercapto-7-methyl-5-oxo-5H-1,3,4-thiadiazolo[3,2-a]pyrimidine
68967-31-7

2-mercapto-7-methyl-5-oxo-5H-1,3,4-thiadiazolo[3,2-a]pyrimidine

A

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

B

3-amino-6-methyl-1H-pyrimidine-2,4-dione
28004-46-8

3-amino-6-methyl-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
With hydrogenchloride In waterA 24%
B 64%
potassium ethyl xanthogenate
140-89-6

potassium ethyl xanthogenate

thiosemicarbazide
79-19-6

thiosemicarbazide

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

Conditions
ConditionsYield
In water64%
thiosemicarbazide
79-19-6

thiosemicarbazide

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

Conditions
ConditionsYield
With carbon disulfide In N-methyl-acetamide; ethanol
With carbon disulfide In N-methyl-acetamide; ethanol; benzene
With carbon disulfide In N-methyl-acetamide; benzene42 wt. %
With carbon disulfide In N-methyl-acetamide
bis(2-mercapto-5-amino-1,3,4-thiadiazole)copper(II)

bis(2-mercapto-5-amino-1,3,4-thiadiazole)copper(II)

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

Conditions
ConditionsYield
With sodiumsulfide nonahydrate
5-thiocyanato-1,3,4-thiadiazol-2-amine
16672-04-1

5-thiocyanato-1,3,4-thiadiazol-2-amine

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

Conditions
ConditionsYield
With sodium tetrahydroborate In ethanol at 0 - 20℃; for 1h;
3-glycidoxypropyltrimethoxysilane
2530-83-8

3-glycidoxypropyltrimethoxysilane

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

C11H23N3O5S2Si

C11H23N3O5S2Si

Conditions
ConditionsYield
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole In methanol
Stage #2: 3-glycidoxypropyltrimethoxysilane In methanol at 65℃; for 18h;
100%
In methanol at 65℃; for 18h;
C20H36Au4N4O12S4

C20H36Au4N4O12S4

potassium carbonate
584-08-7

potassium carbonate

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

potassium hydroxide

potassium hydroxide

C7H9AuN4O3S3(1-)*K(1+)

C7H9AuN4O3S3(1-)*K(1+)

Conditions
ConditionsYield
In water at 60℃;100%
copper(ll) sulfate pentahydrate

copper(ll) sulfate pentahydrate

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

bis(2-mercapto-5-amino-1,3,4-thiadiazole)copper(II)

bis(2-mercapto-5-amino-1,3,4-thiadiazole)copper(II)

Conditions
ConditionsYield
In ethyl acetate Milling; Green chemistry;99.6%
With sodium hydroxide In water at 40℃; for 0.333333h; Temperature;9.66 g
aluminum(III) sulfate

aluminum(III) sulfate

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

3C2H2N3S2(1-)*Al(3+)

3C2H2N3S2(1-)*Al(3+)

Conditions
ConditionsYield
In dimethyl sulfoxide Milling; Green chemistry;99.5%
2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2C2H2N3S2(1-)*Mn(2+)

2C2H2N3S2(1-)*Mn(2+)

Conditions
ConditionsYield
In acetonitrile Milling; Green chemistry;99.4%
tin (II) sulfate

tin (II) sulfate

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2C2H2N3S2(1-)*Sn(2+)

2C2H2N3S2(1-)*Sn(2+)

Conditions
ConditionsYield
In butan-1-ol Milling; Green chemistry;99.2%
zinc(II) acetate dihydrate
5970-45-6

zinc(II) acetate dihydrate

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

bis(2-mercapto-5-amino-1,3,4-thiadiazole)zinc(II)

bis(2-mercapto-5-amino-1,3,4-thiadiazole)zinc(II)

Conditions
ConditionsYield
In water Milling; Green chemistry;99.1%
In water High Pressure; hydrothermal synthesis;76%
ferrous phosphate octahydrate

ferrous phosphate octahydrate

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2C2H2N3S2(1-)*Fe(2+)

2C2H2N3S2(1-)*Fe(2+)

Conditions
ConditionsYield
In chloroform Milling; Green chemistry;99.1%
nickel(II) sulphate

nickel(II) sulphate

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2C2H2N3S2(1-)*Ni(2+)

2C2H2N3S2(1-)*Ni(2+)

Conditions
ConditionsYield
In 2-methyl-propan-1-ol Milling; Green chemistry;99.1%
2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

3-iodopropyltrimethoxysilane
14867-28-8

3-iodopropyltrimethoxysilane

2-amino-5-[3-(trimethoxysilyl)propylthio]-1,3,4-thiadiazole

2-amino-5-[3-(trimethoxysilyl)propylthio]-1,3,4-thiadiazole

Conditions
ConditionsYield
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With sodium methylate In methanol at 20℃; for 0.5h;
Stage #2: 3-iodopropyltrimethoxysilane In methanol at 37 - 40℃; for 5.5h;
98.7%
benzyl chloride
100-44-7

benzyl chloride

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2-amino-5-benzylthio-1,3,4-thiadiazole
25660-71-3

2-amino-5-benzylthio-1,3,4-thiadiazole

Conditions
ConditionsYield
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With potassium hydroxide In ethanol; water at 20 - 30℃; for 0.166667h;
Stage #2: benzyl chloride In ethanol; water at 20 - 30℃;
98%
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With pyridine; triethylamine for 0.166667h;
Stage #2: benzyl chloride at 20℃; for 3h;
93.4%
With sodium methylate In methanol at 20℃;85%
C26H36BClO7

C26H36BClO7

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

C28H38BN3O7S2

C28H38BN3O7S2

Conditions
ConditionsYield
With triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃;97.8%
C27H38BClO8

C27H38BClO8

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

C29H40BN3O8S2

C29H40BN3O8S2

Conditions
ConditionsYield
With triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃;97.7%
2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

4-Fluorobenzyl bromide
459-46-1

4-Fluorobenzyl bromide

5-((4-fluorobenzyl)thio)-1,3,4-thiadiazol-2-amine
299936-22-4

5-((4-fluorobenzyl)thio)-1,3,4-thiadiazol-2-amine

Conditions
ConditionsYield
With sodium hydroxide In water at 22℃; for 15h;97%
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With potassium hydroxide In ethanol for 0.166667h;
Stage #2: 4-Fluorobenzyl bromide In ethanol for 2h;
88%
With sodium methylate In methanol at 20℃;69%
With Amberlite(R) IRA-67 In acetonitrile at 20℃; for 24h;
benzyl bromide
100-39-0

benzyl bromide

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2-amino-5-benzylthio-1,3,4-thiadiazole
25660-71-3

2-amino-5-benzylthio-1,3,4-thiadiazole

Conditions
ConditionsYield
With sodium hydroxide In water at 22℃; for 15h;96%
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With potassium hydroxide In ethanol for 0.166667h;
Stage #2: benzyl bromide In ethanol for 2h;
90%
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With potassium tert-butylate In tetrahydrofuran Sonication;
Stage #2: benzyl bromide In tetrahydrofuran at 20℃; for 0.333333h; Reagent/catalyst; Sonication;
85%
2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

N-methyl bromomaleimide
65060-93-7

N-methyl bromomaleimide

N-methyl-3-(5-amino-1,3,4-thiadiazol-2-ylthio)-maleimide

N-methyl-3-(5-amino-1,3,4-thiadiazol-2-ylthio)-maleimide

Conditions
ConditionsYield
With triethylamine In water at 20℃; for 6h;96%
2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2-chloromethyl-7-methyl-5-oxo-5H-1,3,4-thiadiazolo<3,2-a>pyrimidine
81516-46-3

2-chloromethyl-7-methyl-5-oxo-5H-1,3,4-thiadiazolo<3,2-a>pyrimidine

2-(5-Amino-[1,3,4]thiadiazol-2-ylsulfanylmethyl)-7-methyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one

2-(5-Amino-[1,3,4]thiadiazol-2-ylsulfanylmethyl)-7-methyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one

Conditions
ConditionsYield
With sodium hydroxide In ethanol for 2h; Heating;95.5%
2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

3-methoxyphenyl isocyanate
18908-07-1

3-methoxyphenyl isocyanate

C10H10N4O2S2

C10H10N4O2S2

Conditions
ConditionsYield
With triethylamine In acetonitrile Reflux;95.1%
In acetonitrile Reflux;
In dichloromethane at 20℃; for 24h; Inert atmosphere;
In dichloromethane at 20℃; Inert atmosphere;
salicylaldehyde
90-02-8

salicylaldehyde

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2-salicylideneimino-5-mercapto-1,3,4-thiadiazole

2-salicylideneimino-5-mercapto-1,3,4-thiadiazole

Conditions
ConditionsYield
In ethanol for 2h; Heating;95%
4-Nitrophthalonitrile
31643-49-9

4-Nitrophthalonitrile

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

4-S-(5-amino-1,3,4-thiadiazole-2-mercapto)phthalonitrile

4-S-(5-amino-1,3,4-thiadiazole-2-mercapto)phthalonitrile

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 40℃; for 3.5h;95%
With triethylamine In dimethyl sulfoxide at 20℃; for 24h; Reagent/catalyst; Solvent; Time; Temperature; Sealed tube; Molecular sieve;81.4%
4-dimethylamino-benzaldehyde
100-10-7

4-dimethylamino-benzaldehyde

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2-mercapto-5-((4-(dimethylamino)benzylidene)amino)-1,3,4-thiadiazole

2-mercapto-5-((4-(dimethylamino)benzylidene)amino)-1,3,4-thiadiazole

Conditions
ConditionsYield
With N-benzyl-N,N,N-triethylammonium chloride at 90℃; for 0.166667h; neat (no solvent);95%
With acetic acid In methanol at 65℃;85%
With acetic acid In ethanol for 4h; Reflux;75%
With magnesium sulfate In dichloromethane at 20℃;59%
In ethanol
Cyclopentyl bromide
137-43-9

Cyclopentyl bromide

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

5-(cyclopentylthio)-1,3,4-thiadiazol-2-amine
40177-33-1

5-(cyclopentylthio)-1,3,4-thiadiazol-2-amine

Conditions
ConditionsYield
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With potassium hydroxide In ethanol for 0.166667h;
Stage #2: Cyclopentyl bromide In ethanol for 2h;
95%
2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

p-trifluoromethyl-phenylisocyanate
1548-13-6

p-trifluoromethyl-phenylisocyanate

1-(5-mercapto-[1,3,4]thiadiazol-2-yl)-3-[4-(trifluoromethyl)phenyl]urea
1370256-57-7

1-(5-mercapto-[1,3,4]thiadiazol-2-yl)-3-[4-(trifluoromethyl)phenyl]urea

Conditions
ConditionsYield
With triethylamine In acetonitrile Reflux;94.6%
In acetonitrile Reflux;
ethyl iodide
75-03-6

ethyl iodide

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2-amino-5-(ethylthio)-1,3,4-thiadiazole
25660-70-2

2-amino-5-(ethylthio)-1,3,4-thiadiazole

Conditions
ConditionsYield
With potassium hydroxide In water; isopropyl alcohol at 0 - 60℃; for 2h;94.4%
With potassium hydroxide In water; isopropyl alcohol at 65℃; for 2.5h; Cooling with ice;80%
With potassium hydroxide In ethanol at 10 - 20℃;52.5%
With sodium carbonate In water
acetylferrocene
1271-55-2

acetylferrocene

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

C14H13FeN3S2

C14H13FeN3S2

Conditions
ConditionsYield
With methanesulfonic acid; choline chloride at 40℃;94.1%
acetic anhydride
108-24-7

acetic anhydride

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2-acetylamino-5-mercapto-1,3,4-thiadiazole
32873-56-6

2-acetylamino-5-mercapto-1,3,4-thiadiazole

Conditions
ConditionsYield
Heating;94%
In acetic acid Heating;90%
With pyridine at 70℃; for 1h; Heating;76.8%
2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

β-naphthol
135-19-3

β-naphthol

(E)-1-((1,3,4-thiadiazol-2-yl)diazenyl)naphthalen-2-ol
1416178-73-8

(E)-1-((1,3,4-thiadiazol-2-yl)diazenyl)naphthalen-2-ol

Conditions
ConditionsYield
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With hydrogenchloride; sodium nitrite In water
Stage #2: β-naphthol With sodium hydroxide In water at -5 - 0℃;
94%
C18H17Cl2FN2O4

C18H17Cl2FN2O4

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

7-(3-(2-(5-amino-1,3,4-thiadiazol-2-ylsulfanyl)acetamido)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-8-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

7-(3-(2-(5-amino-1,3,4-thiadiazol-2-ylsulfanyl)acetamido)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-8-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

Conditions
ConditionsYield
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With potassium carbonate In N,N-dimethyl-formamide for 0.5h;
Stage #2: C18H17Cl2FN2O4 In N,N-dimethyl-formamide at 45℃; for 1.3h;
94%
C19H18Cl2FN3O4

C19H18Cl2FN3O4

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

7-(3-(2-(5-amino-1,3,4-thiadiazol-2-ylsulfanyl)acetamido)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-8-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

7-(3-(2-(5-amino-1,3,4-thiadiazol-2-ylsulfanyl)acetamido)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-8-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

Conditions
ConditionsYield
Stage #1: 2-Amino-5-mercapto-1,3,4-thiadiazole With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: C19H18Cl2FN3O4 In N,N-dimethyl-formamide at 45℃; for 1.3h;
94%

2349-67-9Relevant articles and documents

Synthesis, antibacterial and?antitubercular activities of?some?7-[4-(5-amino-[1,3,4]thiadiazole-2-sulfonyl)-piperazin -1-yl] fluoroquinolonic derivatives

Talath,Gadad

, p. 918 - 924 (2006)

In the present study, a series of 7-[4-(5-amino-1,3,4 thiadiazole-2-sulfonyl)]-1-piperazinyl fluoroquinolonic derivatives VIIa-d were synthesized in good yields and characterized by IR, 1H-NMR, 13C-NMR, FAB Mass spectral and elemental analyses. The compounds were evaluated for their preliminary in vitro antibacterial activity against some Gram-positive and Gram-negative bacteria and selected compounds VIIa, b were screened for antitubercular activity against Mycobacterium tuberculosis H37Rv strain by broth dilution assay method. The antibacterial data of the tested N-sulfonylfluoroquinolones VIIa-d indicated that all the synthesized compounds showed better activity against Gram-positive bacteria S.?aureus, E.?faecelis, Bacillus sp. (MIC = 1-5?μg?ml-1, respectively) compared to reference drugs. The MIC values of tested derivatives connotes that the sparfloxacin and gatifloxacin derivatives VIIc, d were most active against the tested Gram-positive bacterial strains (MIC = 1-5?μg?ml-1). All the tested compounds VIIa-d showed poor activity against the Gram-negative bacteria. The in vitro antitubercular activity reports of selected compounds VIIa, b against M.?tuberculosis strain H37Rv showed moderate activity at MIC of 10?μg?ml-1.

Synthesis and biological assessment of ciprofloxacin-derived 1,3,4-thiadiazoles as anticancer agents

Ahadi, Hamideh,Shokrzadeh, Mohammad,Hosseini-khah, Zahra,Ghassemi barghi, Nasrin,Ghasemian, Majid,Emadi, Elnaz,Zargari, Mehryar,Razzaghi-Asl, Nima,Emami, Saeed

, (2020)

The quinolone-3-carboxylic acid scaffold is essential structure for antibacterial activity of fluoroquinolones such as ciprofloxacin. Modification of 3-carboxylic functionality in this structure can be used for switching its activity from antibacterial to anticancer. Accordingly, a series of C-3 modified ciprofloxacin derivatives containing N-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-carboxamide moiety was synthesized as novel anticancer agents. Most of compounds showed significant activity against MCF-7, A549 and SKOV-3 cancer cells in the MTT assay. In particular, compounds 13a-e and 13g were found to be as potent as standard drug doxorubicin against MCF-7 cell line (IC50s = 3.26–3.90 μM). Furthermore, the 4-fluorobenzyl derivatives 13h and 14b with IC50 values of 3.58 and 2.79 μM exhibited the highest activity against SKOV-3 and A549 cells, being as potent as doxorubicin. Two promising compounds 13e and 13g were further tested for their apoptosis inducing activity and cell cycle arrest. Both compounds could significantly induce apoptosis in MCF-7 cells, while compound 13e was more potent apoptosis inducer resulting in an 18-fold increase in the proportion of apoptotic cells at the IC50 concentration in MCF-7 cells. The cell cycle analysis revealed that compounds 13e and 13g could increase cell portions in the sub-G1 phase, inducing oligonucleosomal DNA fragmentation and apoptosis confirmed by comet assay.

Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity

Abdel-Hamid, Mohammed K.,Abdel-Hafez, Atef A.,El-Koussi, Nawal A.,Mahfouz, Nadia M.,Innocenti, Alessio,Supuran, Claudiu T.

, p. 6975 - 6984 (2007)

A new series of 1,3,4-thiadiazole-2-thione derivatives have been prepared and assayed for the inhibition of three physiologically relevant carbonic anhydrase (CA, EC 4.2.1.1) isozymes, the cytosolic human isozymes I and II, and the transmembrane, tumor-associated hCA IX. Against hCA I the investigated thiones, showed inhibition constants in the range of 2.55-222 μM, against hCA II in the range of 2.0-433 μM, and against hCA IX in the range of 1.25-148 μM. Compound 5c, 4-(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)-1-(5-nitro-2-oxoindolin-3 -ylidene)semicarbazide showed interesting inhibition of the tumor-associated hCA IX with KI value of 1.25 μM, being the first non-sulfonamide type inhibitor of such activity. This result is rather important taking into consideration the known antitumor activity of thiones. In addition, docking of the tested compounds into CA II active site was performed in order to predict the affinity and orientation of these compounds at the isozyme active site. The results showed similar orientation of the target compounds at CA II active site compared with reported sulfonamide type CAIs with the thione group acting as a zinc-binding moiety.

Ultrasound-assisted improved synthesis of 5-(benzylthio)-1,3,4-thiadiazol-2-amine derivatives: an experimental and computational study

Erdogan, Taner

, p. 899 - 912 (2019)

The main objects of this study are: (1) to propose alternative efficient methods for the synthesis of 5-amino-1,3,4-thiadiazole-2-thiol and 5-(benzylthio)-1,3,4-thiadiazol-2-amine derivatives, (2) to investigate the reactions and the chemical species which take place in the investigated reactions computationally via density functional theory (DFT) calculations, (3) to make a comparison between experimental and computationally obtained data, and (4) to make a comparison between the computational methods to find out the best computational technique to simulate the investigated molecules and reactions. The study consists of two parts. In the first part, synthesis of 5-amino-1,3,4-thiadiazole-2-thiol and 5-(benzylthio)-1,3,4-thiadiazol-2-amine derivatives have been carried out. For both syntheses, it has been proposed that the reactions can be carried out effectively with the use of ultrasound. To the best of our knowledge, this is the first use of ultrasound for both reactions. The results showed that ultrasound can increase the efficiency of the investigated reactions and can be a good alternative to conventional methods. In the second part of the study, some DFT calculations have been performed on the chemical species which take place in the investigated reactions. In computational studies, seven different basis sets have been used. In this second part, comparisons have been made (1) between experimental and computationally obtained data, and (2) between the computational techniques to reveal the best method for the investigated molecules.

Mercapto thiadiazole-based sensors with high selectivity and sensitivity for Hg2+ in aqueous solution

Zhang, You-Ming,Liu, Ming-Xia,Lin, Qi,Li, Qiao,Wei, Tai-Bao

, p. 619 - 621 (2010)

Two simple mercapto thiadiazole-based sensors have been synthesised by a convenient method and exhibit excellent sensitivity and selectivity for Hg 2+ in DMSO/H2O (1:1, v/v) aqueous solution. The sensors react with Hg2+ to form stable complexes and the association constants, Ka, are 4.4 × 104 M-1 and 1.0 × 103 M-1, respectively. Furthermore, the detection limit of one sensor towards Hg2+ is 8.0 × 10-7 M.

Synthesis of novel 2-acetamide-5-phenylthio-1,3,4-thiadiazole-containing phenyl urea derivatives as potential VEGFR-2 inhibitors

Ayati, Adileh,Fathi, Parnian,Foroumadi, Alireza,Foroumadi, Roham,Ketabforoosh, Shima H. M. E.,Moghimi, Setareh,Safari, Fatemeh,Salarinejad, Somayeh,Toolabi, Mahsa

, (2022/01/13)

A novel series of 2-acetamide-5-phenylthio-1,3,4-thiadiazol derivatives containing a phenyl urea warhead were synthesized and evaluated as antiproliferative agents. The cytotoxic activities of the newly synthesized compounds were evaluated toward three human cancer cell lines, including HT-29, A431, and PC3, as well as normal HDF cells, using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. The biological results revealed the highest degree of cytotoxic effects for the 4-chloro-containing compound 9e against the A431 cell line. Further assessment by Western blot analysis assay confirmed the induction of apoptosis by compound 9e, with upregulation of Bax and downregulation of Bcl-2 proteins in A431 cancer cells. In addition, compound 9e inhibited the phosphorylation of vascular endothelial growth factor and its receptor (VEGFR-2) in A431 cancer cells while the total level of actin protein was unchanged. These results were confirmed by a three-dimensional cell culture method using the hanging drop technique.

Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis

Faraji, Aram,Oghabi Bakhshaiesh, Tayebeh,Hasanvand, Zaman,Motahari, Rasoul,Nazeri, Elahe,Boshagh, Mohammad Amin,Firoozpour, Loghman,Mehrabi, Hossein,Khalaj, Ali,Esmaeili, Rezvan,Foroumadi, Alireza

, (2020/10/27)

Inhibition of angiogenesis is a promising strategy for the treatment of cancer. Herein, we describe the design and synthesis of thieno[2,3-d]pyrimidine-1,3,4-thiadiazole-aryl urea derivatives 11a-m to evaluate their efficacy in the chick chorioallantoic membrane (CAM) assay. Among target agents, 11i had a considerable activity against prostate cancer cell line, PC3 (IC50 = 3.6 μM). Moreover, induction of apoptosis, good inhibitory activity against the growth of capillary blood vessels, and inhibition of VEGFR-2 phosphorylation were noticeable parameters which convinced us that 11i could be considered as a promising candidate for the discovery of novel drugs to treat tumors, particularly prostate cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2349-67-9